C Bokemeyer

Summary

Country: Germany

Publications

  1. Bokemeyer C, Kollmannsberger C, Stenning S, Hartmann J, Horwich A, Clemm C, et al. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials. Br J Cancer. 2004;91:683-7 pubmed
    ..In conclusion, carboplatin single agent therapy cannot be recommended as standard treatment for any patient subgroup with advanced metastatic seminoma and cisplatin-based combination regimens remain the standard of care. ..
  2. Bokemeyer C, Kollmannsberger C, Harstrick A, Beyer J, Gerl A, Casper J, et al. Treatment of patients with cisplatin-refractory testicular germ-cell cancer. German Testicular Cancer Study Group (GTCSG). Int J Cancer. 1999;83:848-51 pubmed
    ..Future trials combining new active agents may examine alternating treatment strategies in patients with poor-prognostic disease or as salvage treatment. ..
  3. Bokemeyer C, Gillis A, Pompe K, Mayer F, Metzner B, Schleucher N, et al. Clinical impact of germ cell tumor cells in apheresis products of patients receiving high-dose chemotherapy. J Clin Oncol. 2001;19:3029-36 pubmed
    ..Factors such as responsiveness to chemotherapy and tumor mass seem to overcome the importance of potentially re-infused tumor cells. ..
  4. Bokemeyer C, Kollmannsberger C, Oechsle K, Dohmen B, Pfannenberg A, Claussen C, et al. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET. Br J Cancer. 2002;86:506-11 pubmed
    ..It may also be a valuable addition to the prognostic model particularly in the good and intermediate group for further selection of patients who will profit from high-dose chemotherapy. ..
  5. Bokemeyer C, Nichols C, Droz J, Schmoll H, Horwich A, Gerl A, et al. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis. J Clin Oncol. 2002;20:1864-73 pubmed
    ..This outcome is clearly inferior compared with patients with nonseminomatous retroperitoneal primary tumors. ..
  6. Bokemeyer C, Hartmann J, Fossa S, Droz J, Schmol H, Horwich A, et al. Extragonadal germ cell tumors: relation to testicular neoplasia and management options. APMIS. 2003;111:49-59; discussion 59-63 pubmed
    ..Patients with mediastinal nonseminomas have a five-years survival rate of 45%. This outcome is clearly inferior compared to patients with nonseminomatous retroperitoneal primaries who have a five-year survival rate of 62%. ..